Column is an investment fund managing more than $71.3 billion ran by James Evangelista. There are currently 6 companies in Mr. Evangelista’s portfolio. The largest investments include Tenaya Therapeutics, Inc. and Oric Pharmaceuticals, together worth $54.2 billion.
As of 8th August 2024, Column’s top holding is 9,400,290 shares of Tenaya Therapeutics, Inc. currently worth over $29.1 billion and making up 40.9% of the portfolio value.
In addition, the fund holds 3,540,777 shares of Oric Pharmaceuticals worth $25 billion, whose value grew 5.8% in the past six months.
The third-largest holding is Surrozen, Inc. worth $8.87 billion and the next is RAPT Therapeutics worth $8.18 billion, with 2,680,621 shares owned.
Currently, Column's portfolio is worth at least $71.3 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Column office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, James Evangelista serves as the Chief Financial Officer at Column.
In the most recent 13F filing, Column revealed that it had opened a new position in
Sagimet Biosciences Inc. and bought 17,169 shares worth $58.7 million.
The investment fund also strengthened its position in Surrozen, Inc. by buying
182,437 additional shares.
This makes their stake in Surrozen, Inc. total 810,088 shares worth $8.87 billion.
On the other hand, there are companies that Column is getting rid of from its portfolio.
Column closed its position in Ngm Biopharmaceuticals Inc on 15th August 2024.
It sold the previously owned 18,136,735 shares for $15.6 billion.
James Evangelista also disclosed a decreased stake in Oric Pharmaceuticals by approximately 0.1%.
This leaves the value of the investment at $25 billion and 3,540,777 shares.
The two most similar investment funds to Column are Forefront Wealth Management Inc and Jacob Asset Management Of New York. They manage $71.3 billion and $70.9 billion respectively.
Column’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 46.6% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $805 million.
These positions were updated on August 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Tenaya Therapeutics, Inc. |
No change
9,400,290
|
$29,140,899,000 | 40.88% |
| Oric Pharmaceuticals, Inc. |
0.77%
3,540,777
|
$25,033,293,000 | 35.12% |
| Ngm Biopharmaceuticals Inc |
Closed
18,136,735
|
$15,579,455,000 | |
| Surrozen, Inc. |
29.07%
810,088
|
$8,870,464,000 | 12.44% |
| RAPT Therapeutics, Inc. |
No change
2,680,621
|
$8,175,894,000 | 11.47% |
| Sagimet Biosciences Inc. |
Opened
17,169
|
$58,718,000 | 0.08% |
| Revolution Medicines Inc |
No change
46
|
$1,785,000 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 7 holdings | |||